Flowserve swing check valves help increase reliability in chemical applications
Redesigned Flowserve Noble Alloy swing check valve offers corrosion resistance and high reliability
The new design introduces casting technology in lieu of forgings, which reduces the weight of the valve by 45% and offers enhanced bonnet-seal performance. The valve features a recessed hinge pin that is protected from the flow path, integral seat design and a high integrity riveted disc assembly. The valve can be installed horizontally or vertically.
'Flowserve's foundry specialises in the alloys and highly engineered casting processes that helped to create the redesigned Noble Alloy swing check valve,' said Brian Hood, product manager, Flowserve Flow Control Division. 'Even in the most challenging applications, this valve delivers improved performance for customers" most severe applications while helping reduce life-cycle costs.'
The Noble Alloy swing check valve is available with soft or metal seating. It features multiple end connections and bolted bonnet construction.
Noble Alloy also offers a wafer piston check design in cast and forged technology. Forged metal construction remains available for all Noble Alloy valve designs.
You may also like
Trending Articles
You may also like
Manufacturing
New Flowserve digital positioner features predictive diagnostics
Flowserve Corporation, a leading provider of flow control products and services for the global infrastructure markets, has announced the release of the Flowserve Logix 3400MD, the newest member of the Logix series digital positioner family
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months